Clinical Trial Update: Two phosphAte taRGets in End-stage Renal Disease Trial (TARGET) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial targeting two phosphate targets in end-stage renal disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease

Snippet

Sponsor: Unity Health Toronto | Conditions: End-stage Renal Disease | Phase 2 | Status: COMPLETED